This selective mechanism of action means that the compound could potentially improve metabolic health, enhance energy levels, and support sustainable weight management without the harsh side effects often associated with other metabolic enhancers
Final Verdict: Which One Should You Choose
300 Disclaimer and Safety Information This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional
In December 2025, the FDA approved the Wegovy pill, offering a daily oral semaglutide option for patients preferring to avoid injections
Semaglutide is already approved and proven to help most people lose around 15-17% of their body weight, while retatrutide has shown weight loss of up to 24% in trials
These hormonal benefits are often accompanied by improved testicular efficiency and lower oxidative stress ( Front Endocrinol , 2023)